Purdue’s Top Doctor and Researcher Are Leaving Opioid Maker (1)

April 25, 2019, 8:57 PM UTCUpdated: April 25, 2019, 9:34 PM UTC

Purdue Pharma LP said its chief medical officer and top researcher will leave the company in the coming weeks to pursue other opportunities outside the opioid maker.

Purdue, which created the painkiller OxyContin, faces numerous lawsuits over its role in the U.S. addiction and overdose epidemic. Chief Executive Officer Craig Landau has suggested that the company could file for bankruptcy as one option to deal with its potential liability.

One of the executives who plans to leave is Marcelo Bigal, who was hired as chief medical officer in March 2018. He is responsible for medical governance and patient safety oversight ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.